Recently, the 2025 China Distilled Water System Market Research Report and the latest GMP dynamic inspection requirements released by NMPA have brought new development opportunities for tubular multi-effect distilled water machines, a core equipment in high-purity water preparation industry.
With the tightening of pharmaceutical regulatory policies, NMPA has fully implemented dynamic GMP inspection mechanisms since 2024, requiring pure water systems to have continuous online monitoring capabilities and adopt low-pollution, chemical-free technical routes. Meanwhile, the "Industrial Water Conservation Technology Promotion Catalog (2025 Edition)" included efficient distilled water recovery systems, providing policy support for equipment upgrading.
As a key type of multi-effect distillation (MED) equipment, tubular multi-effect distilled water machines have become the first choice for enterprises due to their compliance with pharmacopoeia standards, stable water output, and energy-saving advantages. They can effectively remove pyrogens and particles, producing high-purity sterile water that fully meets the requirements of injection water preparation in biopharmaceutical industry.
Driven by the growth of biopharmaceutical, medical and high-end laboratory markets, the market share of tubular multi-effect distilled water machines has continued to rise, accounting for an important part of the 63.5% share of MED and MVR equipment combined. With the integration of IoT intelligent monitoring functions, they are helping enterprises achieve compliance production and efficiency improvement.
Against the background of industrial upgrading, tubular multi-effect distilled water machines will continue to play a core role in high-purity water preparation, empowering the high-quality development of pharmaceutical and medical industries.
